← Open Payments lookup

CATHERINE LE: Open Payments

NPI 1932144656 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,458 in 35 payments from 14 companies in 2025. Trend: 2023 $620 · 2024 $659 · 2025 $1,458

Food & beverage: $1,458
CompanyPaymentsAmount
ABBVIE INC.7$327
Janssen Biotech, Inc.5$318
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$223
Regeneron Pharmaceuticals, Inc.1$124
Madrigal Pharmaceuticals1$87
Takeda Pharmaceuticals U.S.A., Inc.3$78
Ardelyx, Inc.3$75
Aimmune Therapeutics, Inc.2$54
Novo Nordisk Inc1$42
Ferring Pharmaceuticals Inc.2$35

Products named: TREMFYA, XIFAXAN, DUPIXENT, RINVOQ, REZDIFFRA, IBSRELA, CREON, ENTYVIO.

Industry payments across IN — which companies pay providers there.